Effects of 3-deazaguanosine and 3-deazaguanine on the growth and maturation of the human promyelocytic leukemia cell line, HL-60.
D000963:Antimetabolites / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D006147:Guanine / Q000031:analogs & derivatives* / Q000633:toxicity; D006151:Guanosine / Q000031:analogs & derivatives* / Q000633:toxicity; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000503:physiopathology*; D009173:Mycophenolic Acid / Q000494:pharmacology
D000963:Antimetabolites; D007042:Hypoxanthines; D006151:Guanosine; D019271:Hypoxanthine; C010568:3-deazaguanosine; D006147:Guanine; C010567:3-deazaguanine; D009173:Mycophenolic Acid